Clinical Chemistry Market By Product (Analyzer, Reagents), By Application (Basic Metabolite Panel, Electrolyte Panel, Liver Function Test, Lipid Profile, Kidney Function Test, Thyroid Profile, Specialty Chemical Test) - Growth, Future Prospects & Competitive Analysis, 2017 – 2025

Clinical chemistry, an applied part of biochemistry, is the territory of science that deals with the examination of body fluids for diagnostic and restorative purposes. Clinical chemistry is a tool used in hospitals, clinical laboratories, and physician's offices to test whole blood, serum, plasma, cerebrospinal fluids, and urine samples for the detection of analyte concentration, to find out hematology values, to diagnose disease, to assess metabolic function, or to assess the presence of drugs. The two most common methods deployed in clinical chemistry are photometry and ion-selective electrodes (ISE). In photometry, the analyte concentration is measured by detecting the color produced when the sample is mixed with reagents, whereas in ISE, a sensor is used to determine the electrolyte concentration of the test sample.

Commercially available chemistry analyzers are generally of two types: dry chemistry analyzers and wet chemistry analyzers. Instead of wet reagents, only lyophilized, reconstituted reagents are applied to the slides on which the test sample is applied in a dry chemistry analyzer, and the analyte concentration is measured by the amount of reflected light. The dry chemistry analyzer is gaining popularity among medical professionals due to its efficiency and high-quality clinical outcomes. Wet chemistry tests are widely performed as they provide improved quality test results in a minimum amount of time and reduce waste. The economic advantage of wet clinical analyzers and cost-effective tests would boost the market growth in the coming years.

The report entitled "Clinical Chemistry Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025" offers monetary authorities, officials, business executives, and industry specialists with detailed analysis and investigation to empower them to make key methodologies and business decisions concerning the possibilities of the worldwide clinical chemistry market. The report effectively conveys the comprehensive evaluation of market elements containing drivers, constraints, opportunities, and difficulties. This report also provides existing key patterns and the future scope of the clinical chemistry market, as well as data for the base year 2016 and projected to 2025, taking into account the CAGR from 2017 to 2025.

The global market for clinical chemistry is heavily influenced by increasing incidences of infectious diseases and the growing prevalence of lifestyle diseases such as diabetes and cardiovascular disorders. According to the World Health Organization, the global prevalence of diabetes reached 422 million in 2014; such a high prevalence is expected to be one of the key impact-rendering factors of the clinical chemistry market. The growing geriatric population is one of the primary factors driving market growth since elderly people are most susceptible to infectious diseases and other disabilities. Healthcare initiatives from the government, as well as public and private healthcare facilities, health screening programs, and routine health check-ups, play major roles in driving the overall growth of the clinical chemistry market.

The preference for automated clinical chemistry among medical professionals is on the rise due to the reduction in workload, increase in turn-around time, faster and more accurate results, and improved reproducibility. Growing healthcare infrastructure facilities and the implementation of advanced technology in the healthcare area, along with increasing usage of automation, are anticipated to create opportunities for the clinical chemistry market. However, the high cost of devices and the requirements of skilled professionals might pose some challenges to the smooth growth of the clinical chemistry market.

The global clinical chemistry market has been categorized on the basis of product types such as analyzers and reagents. Analyzers are segmented into fully automated analyzers, semi-automated analyzers, and accessories. Fully automated analyzers are further classified according to tests per hour. Reagents are classified into calibrators, standard, control, and other reagents.

Based on the application of clinical chemistry, the market has been classified as basic metabolite panels, electrolyte panels, liver function tests, lipid profiles, kidney function tests, thyroid profiles, specialty chemical tests, and other biochemical tests. This report contains the cross-sectional data analysis of each and every section containing data for the base year of 2016 and predicts the market through 2025, along with the CAGR calculated from 2017–2025.

On the basis of key geographical regions, the global clinical chemistry market has been classified into five principal areas, which are further cross-sectioned as per the constituent regions:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • India
    • China
    • Japan
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

ELITechGroup, Roche Diagnostics International Ltd., Beckman Coulter, Inc., Thermo Fisher Scientific, Alfa Wassermann, Ortho-Clinical Diagnostics, Abbott, Accurex Biomedical Pvt. Ltd., HORIBA, Ltd., EKF Diagnostics, Furuno Electric Co., Ltd., Medica Corporation, and others are profiled extensively in the clinical chemistry market research report, along with complete business information.

Based on the product type, the global clinical chemistry market is segmented as below:

  • Analyzer
  • Fully Automated Clinical Chemistry Analyzer
  • very large (>2000 tests/hour).
  • Large (1200–2000 tests/hour)
  • Medium (800–1200 tests/hour)
  • Small (400-800)
  • very small
  • Semi-automated Clinical Chemistry Analyzer
  • Accessories
  • Reagents
  • Calibrators
  • Standards
  • Controls
  • Other Reagents

The clinical chemistry reagents segment is projected to hold the largest share in the clinical chemistry market due to the presence of a wide range of reagents like substrates, enzymes, proteins, electrolytes, dyes, and buffers utilized in laboratories. Calibrators assist the analyzer in producing accurate and reliable clinical results after adjusting the analyzer to measure a particular analyte in a test sample. Standard solutions are required to calibrate measuring equipment at a known concentration range of the sample. Control reagents are of the same appearance as the patient's sample and are used to verify the accuracy and acceptability of each test run. The reagents market is anticipated to witness lucrative growth due to the increasing number of clinical test procedures with cost-effective reagents to ensure minimal variation in clinical results. Fully automated clinical chemistry is a medical laboratory instrument with minimal human assistance where manual operation is needed to set the parameters according to demand.

Low cost, easy handling, and simple user interference make the process easy, and these factors drive the inclination of hospitals and medical facilities toward fully automated clinical chemistry. Fully automated analyzers are in high demand in large laboratories where bulk sample diagnosis is critical. Integration of technologically advanced features such as intelligent sample management, large data storage, a barcode tracker for sample identification, and a wireless chip would drive the preference for fully automated devices, which are expected to drive the market in future years. In semi-automated analyzers, the initial part of the process is done manually, and the rest is done by the device. Due to its lower price, it is mostly preferred in small-sized laboratories that demand a low cost of operation.

On the basis of application, the global clinical chemistry market is categorized into the following areas:

  • Basic Metabolite Panel
  • Electrolyte Panel
  • liver function test
  • Lipid Profile
  • kidney function test
  • Thyroid Profile
  • Specialty Chemical Test
  • Other biochemical tests

The basic metabolic panel is identified as the leading segment due to the rising prevalence of lifestyle diseases and metabolic disorders. Upsurging routine health check-ups, assisted by growing health awareness among the public, is one of the key market-driving factors. The clinical chemistry market is being driven by the rising prevalence of lipid profile testing for the detection of cholesterol and lipoprotein levels as a result of sedentary lifestyles and fat-rich diet habits. Electrolyte imbalance occurs in respiratory diseases, renal diseases, and cases of metabolic anomalies, which urged the need for electrolyte panel monitoring.

The American Thyroid Association (ATA) stated that, on average, 12% of the U.S. population develops thyroid disease during their lifetime, and around 20 million Americans have thyroid disease. In the year 2016, an estimated 56,870 adults were estimated to have thyroid cancer; this high prevalence indicated the huge importance of thyroid diagnostics at an early stage. Research funded by the American Thyroid Association for mandatory screening of thyroids in newborns and cost-effective detection methods fueled the market growth of clinical chemistry.

Geographically, the global clinical chemistry market is cumulative for North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.

In the base year 2016, North America was the dominant region in terms of sales revenue in the global clinical chemistry market, followed by Europe as a result of rising health awareness, an emerging focus on better healthy living, and advanced healthcare infrastructure. According to the Centers for Disease Control and Prevention (CDC), more than 29 million people in the United States were affected by diabetes in 2016; such a high prevalence of diabetes mellitus indicated a surge in demand for blood glucose diagnosis, which in turn drove clinical chemistry market growth.

Heart disease is abruptly escalating in the United States due to changes in lifestyle and diet patterns, which are responsible for around 600,000 deaths in the United States per year. As a result, the market for initiating treatment regimens has been driven by clinical diagnosis of cholesterol and lipid profiles. The market presence of dominant players has influenced the North American clinical chemistry market to grow. Stringent FDA regulatory guidelines in terms of quality assurance might hamper the smooth growth of clinical chemistry. However, a growing number of independent laboratories and physician office labs are expected to have a positive impact on market growth. Emerging health awareness, initiatives taken by the government and other healthcare organizations, and developing healthcare infrastructure are anticipated to fuel market growth in the Asia Pacific region.

The global clinical chemistry market is presented as follows:

  • North America (the United States and Canada)
  • Europe (the United Kingdom, Germany, and the rest of the European countries)
  • Asia Pacific (India, Japan, China, South Korea, and the rest of Asia Pacific countries)
  • Latin America (Mexico, Brazil, and the rest of LATAM countries)
  • Middle East and Africa (GCC, South Africa, and the rest of the MEA) 

Frequently Asked Question:

The market for Clinical Chemistry Market is expected to reach USD$ 9.75 Bn in 2025.

The Clinical Chemistry Market is expected to see significant CAGR growth over the coming years, at 5.1%.

The report is forecasted from 2017 -2025.

The base year of this report is 2016.

Alfa Wassermann, Ortho-Clinical Diagnostics, Abbott, Accurex Biomedical Pvt. Ltd., HORIBA, Ltd., EKF Diagnostics, Furuno Electric Co., Ltd. are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Dec 2017
Category:  Medical Devices
Report ID:   58908
Report Format:   PDF
Pages:   120
Rating:    4.5 (70)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support